Hormone Therapy for Menopause: A Shift in Perspective?

USAThu Oct 02 2025
The FDA is considering changes to the strictest warning labels on hormone replacement therapies for menopause symptoms. This move comes after years of debate over the risks and benefits of these treatments. The current black box warning, the most severe type of alert, has been in place since 2003. It highlights increased risks of cancers, strokes, blood clots, and dementia for women using estrogen-based therapies. These warnings were based on a large study from the late 1990s, which found higher risks for women taking estrogen pills after menopause. After the warning was introduced, prescriptions for these therapies dropped by over 70%. Many women stopped using them, even though they helped manage symptoms like hot flashes and mood swings. This has led to undertreatment of menopausal symptoms, which can be quite severe. Recent analyses suggest that hormone therapy may be safer and more beneficial when started before age 60 or within 10 years of menopause. Experts argue that the current warning is too broad and may be preventing women from accessing effective treatments. Some forms of hormone therapy, like low-dose vaginal estrogen, may not raise cancer risks. Yet, the black box warning still applies to all estrogen-based therapies, which experts say is a mistake. They argue that the warning should be removed for therapies with a better balance of risks and benefits. The FDA held a meeting in July to discuss these issues. Experts urged the agency to remove the warning label, stating that it is harming women by preventing them from using beneficial therapies. However, not all experts agree. Some believe that more research is needed to fully understand the long-term effects of hormone therapy. Women's health experts emphasize the importance of individualized treatment. They encourage women to talk to their doctors about hormone therapy, considering their personal health risks and benefits. The goal is to find a balance between managing menopausal symptoms and minimizing potential risks.
https://localnews.ai/article/hormone-therapy-for-menopause-a-shift-in-perspective-f21ed8dc

questions

    Could the pharmaceutical industry be influencing the FDA's decision to change the black box warning to boost sales of hormone replacement therapy?
    If hormone therapy helps with memory loss, will women finally remember where they left their keys and phones?
    What are the potential biases in the studies that support the removal of the black box warning, and how do they affect the conclusions?

actions